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Abstract
Small molecule secondary metabolites produced by organisms such as plants, bacteria, and fungi 
form a fascinating and important group of natural products, many of which have shown promise as 
medicines. Fungi in particular have been important sources of natural product polyketide 
pharmaceuticals. While the structural complexity of these polyketides makes them interesting and 
useful bioactive compounds, these same features also make them difficult and expensive to 
prepare and scale-up using synthetic methods. Currently, nearly all commercial polyketides are 
prepared through fermentation or semi-synthesis. However, elucidation and engineering of 
polyketide pathways in the native filamentous fungi hosts are often hampered due to a lack of 
established genetic tools and of understanding of the regulation of fungal secondary metabolisms. 
Saccharomyces cerevisiae has many advantages beneficial to the study and development of 
polyketide pathways from filamentous fungi due to its extensive genetic toolbox and well-studied 
metabolism. This review highlights the benefits S. cerevisiae provides as a tool for mining, 
studying, and engineering fungal polyketide synthases (PKSs), as well as notable insights this 
versatile tool has given us into the mechanisms and products of fungal PKSs.
1. Introduction
Small molecule secondary metabolites produced by organisms such as plants, bacteria, and 
fungi form a fascinating and important group of natural products. Many of these natural 
products with diverse bioactivities have been important sources of medicines. 
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Approximately 50% of all new chemical entity small molecules approved by the U.S. Food 
and Drug Administration (FDA) from 2000–2010 and nearly half of the drugs approved 
from 1994–2008 were derived from natural products (Newman and Cragg, 2012; Harvey, 
2008).
Polyketides are one of the major classes of natural products with diverse chemical structures 
and biological activities. Fungi in particular have been important sources of polyketide 
pharmaceuticals or virulence factors (Hertweck, 2009), and several examples of well-known 
fungal polyketides are included in Figure 1. Many of these compounds display clinically 
relevant activities against human diseases. For example, simvastatin, lovastatin, and 
mevastatin are all structurally related, natural product-derived cholesterol-lowering 
medications currently on the market (Barrios-González and Miranda, 2010). Squalestatin is 
an inhibitor of squalene synthases and also shows potential as a cholesterol-lowering 
medication (Baxter et al., 1992). In addition to the compounds displaying anti-
hypercholesterolemia properties, several polyketides have been studied for their potential 
anticancer activities. Specifically, cytochalasin E has been shown to inhibit angiogenesis and 
tumor growth, and has been considered for use in cancer treatment and age-related macular 
degeneration (Udagawa et al., 2000). Brefeldin A has also shown potential as an anticancer 
agent due to its induction of apoptosis in several cancer cell lines, shown to be via activation 
of the mitochondria-mediated cell death pathway in ovarian cancer cells (He et al., 2013; 
Lee et al., 2013). Mycophenolic acid is a known immunosuppressant for organ-transplant 
patients but has shown potential as a method of inducing apoptosis in tumor cells through 
inosine monophosphate dehydrogenase (IMPDH) inhibition (Bentley, 2000). Griseofulvin 
was launched as antifungal agent in the 1950s and has now attracted renewed attention for 
its anticancer and antiviral activities (Petersen et al., 2014). However, there are fungal 
polyketides hazardous to human health, such as aflatoxins, which are the primary 
mycotoxins produced by some Aspergillus sp. and considered to be the most potent naturally 
occurring carcinogens (Roze et al., 2013).
While the structural complexity of these polyketides makes them interesting and useful 
bioactive compounds, these same features also make them difficult and expensive to prepare 
and scale-up using synthetic methods. Currently, nearly all commercial polyketides are 
prepared through fermentation or semi-synthesis (Dechert-Schmitt et al., 2014; Wong and 
Khosla, 2012). Thus, elucidating the biosynthetic pathways of polyketides and 
characterizing the pathway enzymes is necessary for the production and diversification of 
natural products for pharmaceutical applications (Tibrewal and Tang, 2014). However, 
efforts to elucidate and engineer polyketide pathways in the native filamentous fungi hosts 
are often hampered for the following reasons: 1) many fungal hosts lack established genetic 
tools; 2) the native hosts of desired natural products may have low biomass accumulation 
and produce low concentrations of the desired product; 3) fungal hosts often produce many 
secondary metabolites that can lead to significant background, allowing the possibility of 
cross-reactivity between pathways, and complicating the analysis of specific pathways; 4) 
transcriptional regulation of fungal natural product clusters is complex and not fully 
understood; and 5) there is no universal expression system with specified culture conditions 
that can be applied uniformly to fungal natural product pathways and their native hosts 
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(Anyaogu and Mortensen, 2015; Brakhage, 2013; Schümann and Hertweck, 2006; Siddiqui 
et al., 2012). For these reasons, a versatile heterologous host for the study and engineering of 
fungal polyketide synthases (PKSs) is desired.
As one of the most intensively studied single-celled eukaryotes in fundamental and applied 
molecular biology research, Saccharomyces cerevisiae has proven to be a useful and 
prominent industrial host for recombinant protein production (Mattanovich et al., 2012). S. 
cerevisiae is widely used not only in the food and beverage industry, but also in the 
production of bioethanol and fine chemicals (Nevoigt, 2008). Specifically, S. cerevisiae has 
many advantages beneficial to the elucidation and engineering of heterologous biosynthetic 
pathways from filamentous fungi: 1) A number of genetic tools for protein expression and 
pathway construction in yeast have been developed; 2) it is a unicellular organism well-
suited for large scale fermentation; 3) S. cerevisiae has a limited native secondary 
metabolism, which minimizes the background and potential interference with heterologous 
pathways; 4) S. cerevisiae grows more rapidly than most filamentous fungi and it is 
considered a GRAS (generally regarded as safe) organism by the FDA (Nevoigt, 2008). In 
addition, yeast naturally produces common polyketide building blocks such as acetyl-CoA 
and malonyl-CoA; as well cofactors such as NADPH and S-adnesylmethioine, which 
facilitate the production of fungal polyketides with minimal integration of heterologous 
genes (Kealey et al., 1998). Like filamentous fungi, yeast is also classified as a fungus and is 
expected to be a capable expression host for fungal proteins that are important for polyketide 
pathways. For example, S. cerevisiae can functionally express eukaryotic cytochrome P450s 
because these enzymes often anchor in the endoplasmic reticulum, which is absent in 
prokaryotes (Pompon et al., 1996).
Using yeast as a heterologous host presents some challenges, such as required genes for PKS 
activation, an inability to splice most fungal introns, low production of necessary precursors, 
a lack of compartmentalization, and potential toxicity. However, the advantages of S. 
cerevisiae have allowed increased understanding of fungal polyketide pathways and 
biosynthesis (Tsunematsu et al., 2013). For example, of the polyketides in Figure 1, the 
lovastatin and brefeldin A biosynthetic pathways were identified using heterologous yeast 
expression (Barriuso et al., 2011; Ma et al., 2009; Zabala et al., 2014), and the effects of 
statins, brefeldin A, mycophenolic acid, and griseofulvin have all been studied in yeast 
(Athlin et al., 1987; Desmoucelles et al., 2002; Kuranda et al., 2010; Leszczynska et al., 
2009; Maciejak et al., 2013; Shah and Klausner, 1993). Aflatoxin pathway genes have been 
expressed heterologously in yeast in order to study aflatoxin biosynthesis, and its mode of 
action has also been studied using yeast (Fasullo et al., 2008; Kelly et al., 2002; Yabe et al., 
2012). This review will focus on the use of S. cerevisiae as a tool for the discovery, study, 
and production of fungal PKSs and their natural products.
2. Introduction to polyketide synthases
The diverse structures of polyketides are biosynthesized from short-chain carboxylic acid 
units by PKSs (Hertweck, 2009). PKSs have been classified into type I, type II and type III 
based on their product profiles and catalytic domain architecture (Shen, 2003) Type I PKSs 
are large multidomain enzymes in which catalytic sites are juxtaposed in an assembly line 
Bond et al. Page 3













fashion. The three essential domains for the elongation of the polyketide chain are β-
ketoacyl synthase (KS), acyltransferase (AT) and acyl carrier protein (ACP). Other domains 
that control the degree of reduction of β-keto groups may be present. These are 
ketoreductase (KR), dehydratase (DH) and enoyl reductase (ER) domains. Other frequently 
found tailoring domains include the methyltransferase (MT) domain, which introduces an α-
methyl group immediately after a round of chain elongation; the thioesterase (TE) domain, 
which releases the polyketide product from the enzyme by hydrolysis, esterification or 
macrocyclization (Keatinge-Clay, 2012); the reductase (R) domain which releases the 
polyketide product from the enzyme by two or four electron reduction or Dieckmann 
condensation (Du and Lou, 2010); a special type of TE domain called TE/CLC (Claisen-like 
cyclase) which catalyses Claisen-type condensations to release the products (Chooi and 
Tang, 2012). Type II PKSs are a set of multienzyme complexes that act iteratively and are 
frequently responsible for the biosynthesis of aromatic polyketides in bacteria. Type III 
PKSs are homodimers of KSs which catalyze the priming, extension, and cyclization of 
small polyketides, such as chalcone, in an ACP-independent fashion. (Shen, 2003; Yu et al., 
2012).
The majority of PKSs from filamentous fungi are type I PKSs. Unlike the multimodular 
bacterial type I PKSs that operate in a collinear fashion in which each set of domains (a 
module) are used once in the construction of the polyketide, fungal type I PKSs contain only 
one set of catalytic domains which are used iteratively in a well-programmed fashion to 
biosynthesize the final products. Hence, fungal PKSs are also known as iterative type I 
PKSs (iPKSs) (Figure 2). Furthermore, based on the extent of β-keto reduction catalyzed by 
the iPKSs, the fungal iPKSs can be classified into three subgroups: nonreducing PKSs (NR-
PKSs) that produce aromatic compounds such as norsolorinic acid, the precursor to aflatoxin 
(Yu et al., 2004), via the product template (PT) domain which is necessary for synthesizing 
these ring-shaped products (Chooi and Tang, 2012); partially-reducing PKSs (PR-PKSs) that 
produce compounds such as 6-methylsalicylic acid (6-MSA) (Beck et al., 1990); and highly-
reducing PKSs (HR-PKSs) that produce more reduced compounds such as lovastatin (Chooi 
and Tang, 2012; Cox, 2007). In addition, an HR-PKS can be fused to a nonribosomal 
peptide synthetase (NRPS) module to form a hybrid PKS-NRPS, which can lead to the 
biosynthesis of tetramic acid-containing products (Boettger and Hertweck, 2013). 
Collectively, the different combinations and programming rules of the iPKSs, along with 
further tailoring of the initial scaffolds by other enzymes, have led to the tremendous 
structural and functional diversity of polyketides isolated from fungal species.
3. The S. cerevisiae toolbox for cloning and enzyme reconstitution
3.1 Molecular biology tools of S. cerevisiae for cloning and reconstitution of heterologous 
pathways
Polyketides and other secondary metabolites are biosynthesized by a series of enzymes 
encoded by genes that are typically clustered together in the genomes of the producing 
organisms (Smith et al., 1990a). The clustering of related genes has been instrumental in the 
discovery and engineering of natural product pathways in both bacteria and fungi (Keller et 
al., 2005). Due to this clustering, the cloning and expression of polyketide biosynthetic 
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enzymes can be accomplished with only one continuous genomic DNA fragment containing 
the entire cluster. However, the cloning or assembly of the pathway in a suitable vector is 
still a challenge because the large size of most gene clusters, or even a single PKS-encoding 
gene (iPKSs genes are typically ~10 kB), is usually too large to be amplified by PCR 
efficiently and correctly.
One strategy to capture entire gene clusters is to construct a genomic DNA library with a 
suitable vector and chemically screen for clones that may carry a functional cluster. For 
example, in the first heterologous expression of penicillin, a cosmid containing the penicillin 
biosynthetic gene cluster from Penicillium chrysogenum was screened from a cosmid library 
using a DNA probe of the homologous isopenicillin N synthetase from Flavobacterium sp. 
SC 12,154. This cosmid was then transformed into Neurospora crassa and Aspergillus 
niger, which led to the production of authentic penicillin V in both transformed hosts (Smith 
et al., 1990b). However, this method can fail when the size of the gene cluster is larger than 
the capacity of a cosmid, or the library does not include a cosmid clone that contains all of 
the genes involved in the biosynthesis of the natural product. Recently, Bok et al. 
constructed an unbiased shuttle BAC library of Aspergillus terreus ATCC2054 with the 
vector containing both the E. coli replicon and Aspergillus autonomously replication 
sequence (AMA1). The average insert size was about 100 kb, which can cover all genes and 
regulatory elements of the biosynthetic pathway and be used successfully in the 
heterologous expression of secondary metabolites (Bok et al., 2015). However, the 
construction of high quality unbiased BAC library is time-consuming and labor-intensive, so 
alternative solutions have been explored using S. cerevisiae.
Yeast has been developed extensively as a synthetic biology tool for the cloning and capture 
of entire biosynthetic gene clusters (Figure 3). One significant advantage of yeast is that 
homologous recombination takes place far more frequently than ligation or non-homologous 
end joining during S. cerevisiae DNA repair (Van Leeuwen et al., 2015). This feature has 
been exploited to construct vectors containing large gene clusters. Overlapping DNA pieces 
and a linearized vector can be co-transformed into yeast spheroplasts, and the DNA 
fragments can then be joined by homologous recombination to form intact, selectable 
vectors. This method is generally known as Transformation-associated Recombination 
(TAR) as well as other names such as DNA assembler (Larionov et al., 1996; Shao et al., 
2009). Oldenburg et al. investigated the efficiency of TAR cloning with different lengths of 
homologous overlaps, and confirmed that while 40 bp of overlap produced optimal results, 
as few as 20 bp of overlap could generate the desired product (Oldenburg et al., 1997). TAR 
cloning is exceptionally simple and efficient, especially in the rapid cloning of large DNA 
genes or gene clusters, without using restriction enzymes or being limited by PCR product 
sizes (Kouprina and Larionov, 2006).
TAR has been used to assemble two or more overlapping cosmids in one step. Feng et al 
used TAR in S. cerevisiae to assemble the entire fluostatins biosynthetic gene cluster from a 
bacterial environmental DNA (eDNA) library. Initially, when the cosmid library was 
screened, they found that the fluostatins cluster was located across two different cosmids. In 
order to assemble the entire cluster, a S. cerevisiae/Escherichia coli/Streptomyces capture 
vector was designed with 1 kb homology regions matched to the boundaries of the gene 
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cluster. The linearized vector and the two cosmids were then co-transformed into yeast and 
homologously recombined (Feng et al., 2010). Yeast based TAR has also been used to 
capture large DNA fragments from the genome directly (Kouprina and Larionov, 2006). 
Analysis of the genome of a marine bacterium, Saccharomonospora sp. CNQ-490, by 
Yamanaka et al revealed a putative NRPS gene cluster similar to the gene cluster 
responsible for synthesis of the antibiotic daptomycin in Streptomyces roseosporus. To mine 
this gene cluster, 1 kb DNA fragments matching the boundaries of the targeted gene cluster 
were cloned by PCR and inserted into the capture vector. The linearized capture plasmid and 
genomic DNA were co-transformed into yeast to capture the cluster. The resultant plasmid 
carrying the cluster was directly used for heterologous expression, leading to the 
heterologous production of taromycin A (Yamanaka et al., 2014).
For accurate and efficient cloning of large fungal iPKSs genes, PCR combined with yeast 
homologous recombination has been widely used in recent years. A common strategy to 
clone large intron-free iPKSs genes from cDNA for yeast expression is to first PCR amplify 
several overlapping fragments from the cDNA of the iPKSs gene, followed by one-step 
recombination into the desired expression vector in yeast. The use of cDNA is to guarantee 
the correct mRNA processing in the yeast. One recent example is the cloning and 
reconstitution of iPKSs AurA from the aurovertin biosynthetic gene cluster in 
Calcarisporium arbuscula. Mao et al amplified three overlapping fragments covering the 
intron-free aurA cDNA. The two 5′ and 3′ pieces also contained overlapping regions with 
the 2μ yeast vector pXW55, which led to placement of the entire aurA gene in the vector 
under control of the ADH2 promoter. The resulting yeast strain containing the desired 
plasmid was then used directly to elucidate the product of the iPKSs through expression of 
the encoded enzymes and analysis of the resulting products (Mao et al., 2015). Other 
examples of TAR-based assembly of iPKSs include cazF and cazM from the chaetoviridin 
biosynthetic gene cluster in Chaetomium globosum (Winter et al., 2015; Winter et al., 
2012a); bref-PKS from the biosynthetic gene cluster of brefeldin A in Eupenicillium 
brefeldianum (Zabala et al., 2014); and fma-PKS from the biosynthetic gene cluster of 
fumagillin in Aspergillus fumigatus (Lin et al., 2013). A variation of this strategy is to first 
assemble the entire iPKSs gene using overlap extension PCR (OE-PCR), followed by 
transformation into yeast along with the vector to yield the intact expression plasmid via 
recombination. This ExRec (overlap Extension PCR-yeast homologous recombination) 
method described by Ishiuchi et al was used to successfully reconstitute iPKSs from 
Chaetomium globosum and Coprinopsis cinerea (Ishiuchi et al., 2012).
Yeast homologous recombination has also been used in the refactoring of multi-gene fungal 
biosynthetic pathways for heterologous reconstitution in model hosts. Pahirulzaman et al 
reconstructed the four gene tenellin biosynthetic pathway from Beauveria bassiana for 
expression in Aspergillus oryzae. The three tailoring genes were first recombined into a 
single expression vector under the control of three different promoters. The PKS-NRPS gene 
was first cloned in a separate plasmid, followed by insertion into the three-gene plasmid via 
Gateway-mediated recombination in vitro (Pahirulzaman et al., 2012). Kakule et al also 
employed yeast homologous recombination to construct cryptic heterologous fungal PKS 
pathways in Fusarium heterosporum. The genes of interest were combined into a S. 
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cerevisiae/E. coli /F. heterosporum shuttle vector via yeast homologous recombination, 
amplified in E. coli, and expressed in F. heterosporum. The PKS CpaS from Aspergillus 
flavus, the PKS LovB and enoylreductase LovC from A. terreus, and two putative PKS-
NRPSs, PrlS and PrlC, from endophytic fungus NRRL 50135 were all successfully 
reconstituted in F. heterosporum via this strategy, leading to production of up to 1 g/L of the 
encoded polyketide (Kakule et al., 2014).
3.2 S. cerevisiae as a platform for PKS protein expression and purification
Purified iPKSs enzymes from fungal PKS biosynthetic pathways are needed for the 
functional characterization of their unique programming rules. Complete understanding of 
PKSs will also enable their abilities to be exploited to benefit the structural diversification, 
activity optimization, and generation of “unnatural” natural products (Tibrewal and Tang, 
2014). As an expression host for fungal proteins, S. cerevisiae has many advantages 
compared to prokaryotic or more complex eukaryotic hosts. Unlike bacterial hosts, such as 
E.coli, S. cerevisiae has the machinery for secretory pathways and post-translational 
modifications (Mattanovich et al., 2012). Compared to mammalian and plant cells, S. 
cerevisiae has fast growth and allows easy genetic manipulation.
Nevertheless, there are some genetic modifications that were made to S. cerevisiae to ensure 
functional expression of iPKSs. Deletion of the two vacuolar protease genes (PEP4 and 
PRB1), encoding the aspartyl protease and proteinase B respectively, significantly increases 
the expression level of recombinant fungal iPKSs. The strain BJ5464 (MATα ura3-52 his3-
Δ200 leu2-Δ1 trp1 pep4::HIS3 prb1 Δ1.6R can1 GAL) was therefore chosen for protein 
expression (Cardenas and Da Silva, 2014; Jones, 1991). In addition, the yeast host must 
ensure correct post-translational modification of the ACP domain of iPKSs. The active site 
serine of ACPs must be modified with a phophopantetheinyl moeity to afford the holo 
version. While yeast has its endogenous 4′-phosphopantetheine (pPant) transferase that 
transfers pPant from coenzyme A to ACP domain of fatty acid synthases, the ACP domain 
of most fungal iPKSs cannot be modified and hence the iPKSs is not active. Kealey et al 
confirmed that there were almost no functional 6-methylsalicylic acid synthases (6-MSAS) 
expressed in the S. cerevisiae without a heterologous pPant transferase (Kealey et al., 1998; 
Lee et al., 2009). To this end, npgA, a pPant transferase gene from Aspergillus nidulans (Lee 
et al., 2009; Wattanachaisaereekul et al., 2007) was integrated into the genome of S. 
cerevisiae BJ5464 to yield BJ5464-NpgA. Using a sensitive fluorescent assay, the authors 
showed that expressed fungal PKSs were efficiently phosphopantetheinylated in the 
engineered strain (Lee et al., 2009). This strain has subsequently been used widely in the 
expression and purification of functional iPKSs, as first demonstrated with the 335 kDa 
lovastatin nonaketide synthase LovB (Ma et al., 2009).
4. Yeast as a platform for studying the function of fungal iPKSs
S. cerevisiae has been used extensively as a host for the expression and characterization of 
iPKS pathways, and to link fungal polyketide natural products to the gene clusters that 
produce them. For example, while investigating the biosynthesis of the protein transport-
inhibitor Brefeldin A (BFA), Zabala et al sequenced the producing organism Eupenicillium 
brefeldianum ATCC 58665. From the numerous gene clusters that contained iPKSs, one 
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putative gene cluster encoding an HR-PKS and numerous P450 genes was proposed to be 
most likely involved in BFA biosynthesis. Genetic manipulation of the producing organism 
proved to be extraordinarily difficult. Therefore, the authors performed direct expression in 
yeast to investigate the role of the HR-PKS. The HR-PKS gene and the partnering 
thiohydrolase gene were cloned into two vectors from cDNA and heterologously expressed 
in S. cerevisiae BJ5464-NpgA. While the authors did not observe the completed core 
structure of BFA, an acyclic octaketide consistent with the length of BFA was recovered. 
The oxidation patterns of the octaketide product were consistent with those observed in 
BFA, thereby providing strong evidence linking this gene cluster to BFA (Zabala et al., 
2014).
Yeast has also been used to connect an orphan NR-PKS gene cluster to the biosynthesis of 
fungal aromatic polyketide TAN-1612. Li et al identified a candidate cluster in Aspergillus 
niger that was presumed to be involved in the production of known compound TAN-1612. 
To verify the function of this cluster, the putative NR-PKS encoded by the adaA gene was 
cloned from cDNA into a yeast 2μ expression plasmid and the three tailoring genes adaB-D 
from the cluster were cloned into a separate plasmid. After two days of culturing, S. 
cerevisiae BJ5464-NpgA expressing these two plasmids produced TAN-1612 (Li et al., 
2011). Subsequent investigations using the yeast host revealed the product of the NR-PKS 
alone, as well as the individual functions of the tailoring enzymes. Similarly, Zhou et al 
utilized yeast to confirm that two iPKSs, an HR-PKS Rdc5 and an NR-PKS Rdc1, were 
involved in the biosynthesis of the radicicol precursor in Pochonia chlamydosporia. 
Heterologous expression of these iPKSs, cloned from genomic DNA, was performed in S. 
cerevisiae BJ5464-NpgAand led to the production of (R)-monocillin II, an intermediate in 
radicicol biosynthesis. This result confirmed that the two iPKSs function collaboratively in 
the biosynthesis of the resorcylic acid lactone and allowed a closer study of the functions of 
these enzymes (Zhou et al., 2010). This led to the yeast-based reconstitution of other dual 
iPKSs clusters from fungi, including those of chaetoviridine, resorcylides, lasiodiplodins, 
and cuvularins (Xu et al., 2014).
Chooi et al. sought to identify virulence factors from Parastagonospora nodorum, a wheat 
pathogen affecting wheat yields globally. In the course of their investigation, they found that 
SN477, a PR-PKS gene, was highly upregulated during the pathogen infection. When 
SN477, was cloned from cDNA under the ADH2 promoter and transformed into S. 
cerevisiae BJ5464-NpgA, (R)-mellein was produced by the yeast host, revealing that SN477 
is the only enzyme required for (R)-mellein synthesis. Though (R)-mellein showed no 
relevance to the virulence against wheat, it was able inhibit the germination of wheat seeds 
(Chooi et al., 2015).
In addition to serving as a host for linking polyketide metabolites to their corresponding 
iPKSs, the yeast iPKS expression platform has also proven to be useful in the mechanistic 
studies of these highly programmed machineries. One example is the characterization of 
LovB, an HR-PKS from Aspergillus terreus that is involved in the biosynthesis of the 
cholesterol-lowering compound lovastatin (Kennedy et al., 1999). The low yield of 
functional LovB (335 kDa) recovered from Aspergillus-based expression hosts significantly 
hindered the biochemical study of this model HR-PKS. When expressed from S. cerevisiae 
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BJ5464-NpgA, a purified LovB yield of ~4.5 mg/L was achieved, thereby providing 
sufficient amounts for in vitro biochemical investigations (Ma et al., 2009). Reconstitution 
of LovB with its enoylreductase LovC demonstrated that the enzyme is precisely 
programmed to synthesize the expected product dihydromonacolin L when the needed 
cofactors (NADPH and SAM) are supplied. After perturbing the system through removal of 
one or more of the required cofactors or LovC, LovB produced a series of conjugated α–
pyrones that are drastically different in structure from dihydromonacolin L. However, 
detailed structural characterization of these shunt products revealed that releasing pyrones is 
one mechanism by which LovB can clear its ACP of incorrectly tailored intermediates, 
thereby providing insight into how iPKSs can maintain their product fidelity. Subsequently, 
using the yeast expression platform and in vitro characterization, Xu et al discovered a 
previously hidden thioesterase, LovG, encoded in the pathway to be the enzyme responsible 
for both the release of dihydromonacolin L from LovB and significant increases in its 
turnover rate (Xu et al., 2013a).
Using the same yeast expression host, Xie et al. also reconstituted the activities of the 
lovastatin diketide synthase (LovF) using purified enzymes. While architecturally similar to 
LovB, the authors showed that this enzyme produces an enzyme-bound α-methylbutyrate 
diketide using Fourier Transform Mass Spectrometry (FTMS) of proteolyzed LovF 
fragments. Offloading of the product was demonstrated to be carried out by the 
acyltransferase LovD, which transfers the α-methylbutyrate to the C8-hydroxyl group of 
monacolin J to yield the final product, lovastatin. Kinetic analysis using LovF and smaller 
acyl mimics such as α-methylbutyryl-CoA or α-methylbutyryl-SNAC demonstrated protein-
protein interactions between the LovF ACP domain and LovD are highly specific, as 
significant penalties to the acyltransfer reaction were observed when small molecules 
thioester carriers were used in place of the ACP domain. This was the first demonstrated 
acyltransferase mediated product release from an iPKSs and since then this mechanism has 
been found to be widely adopted by other fungal PKS pathways (Chooi and Tang, 2012; Xie 
et al., 2009). Together with the functional reconstitution of the lovastatin P450 LovA in 
yeast (Barriuso et al., 2011), the entire six-gene biosynthetic pathway of lovastatin has been 
functionally elucidated in S. cerevisiae, paving the way for heterologous pathway 
construction and engineering.
In another example, Wang et al. demonstrated the aryl-aldehyde formation in the 
biosynthesis of an NR-PKS through heterologous expression of a cryptic NR-PKS and an 
NRPS-like gene from Aspergillus terreus in yeast. When the cryptic NR-PKS ATEG03629 
was expressed in S. cerevisiae BJ5464-NpgA, 5-methyl orsellinic acid (5-MOA) was 
produced. However, when both ATEG03629 and ATEG03630, an NRPS-like gene with a 
terminal reductase domain, were co-transformed into the yeast host, 2,4-dihydroxy-5,6-
dimethyl benzaldehyde was produced in addition to 5-MOA. Both ATEG03629 and 
ATEG03630 were cloned from genomic DNA using exons predicted from bioinformatics 
analysis. The in vivo results indicated that the NRPS-like protein catalyzes the aryl-acid to 
aryl-aldehyde conversion. To further confirm the activity of ATEG03630, the enzyme was 
purified from BJ5464-NpgA. In vitro experiments of ATEG03630 with the substrate 5-
MOA and cofactor NADPH confirmed the catalytic activity of ATEG03630. Though these 
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compounds had been reported previously, their biosynthetic origins had never been 
established (Wang et al., 2014).
As the above examples demonstrate, yeast is a useful and versatile tool for production of 
diverse polyketides and their associated mega-enzymes in sufficient quantities for in vitro 
mechanistic studies of iPKSs. These applications of S. cerevisiae improve the knowledge of 
biosynthesis of natural products and accumulate enzyme tools for drug discovery and the 
synthesis of new natural products.
5. Engineering production of fungal PKSs and polyketides in yeast
The deletion of native proteases and the integration of a heterologous pPant transferase have 
been discussed earlier as essential for the functional expression of fungal iPKSs in S. 
cerevisiae. Other methods of increasing the titer of the final polyketide product include 
increasing the supply of the common polyketide precursors acetyl-CoA and malonyl-CoA, 
and introducing self-resistance genes to mitigate the toxicity of final product. These 
metabolic engineering strategies can be employed in the production of both natural and 
engineered, unnatural polyketides in yeast. The route from the discovery of novel 
polyketides to high production in yeast is outlined in Figure 4.
5.1 Strain engineering for high titers via increased precursor production
Increasing the supply of the precursors is one common metabolic engineering strategy to 
increase the titer of the final product (Krivoruchko and Nielsen, 2015). Common polyketide 
precursors acetyl-CoA and malonyl-CoA are produced endogenously by yeast, but 
metabolic engineering is required to produce larger quantities of these substrates. Recent 
efforts to increase precursor production have focused both on enzyme overexpression and 
engineering, as well as on directing carbon towards the desired precursors via deletion of 
competing pathways.
The ACC1 gene encodes acetyl-CoA carboxylase, which catalyzes the conversion of acetyl-
CoA to malonyl-CoA. Wattanachaisaereekul et al overexpressed the native yeast ACC1 
through replacing the native promoter of ACC1 with a strong constitutive TEF1 promoter in 
a 6-MSA polyketide production S. cerevisiae strain, increasing the titer of 6-MSA by 60% 
(Wattanachaisaereekul et al., 2008). Choi et al. improved the activity of ACC1 by site-
directed mutagenesis, leading to 3-fold increases in 6-MSA levels (Choi and Da Silva, 
2014).
Metabolic pathway analysis in the well-studied S. cerevisiae has been used to determine 
how to direct carbon towards the desired product. Cardenas et al specifically increased the 
titer of precursor acetyl-CoA through the deletion of 15 genes identified during pathway 
analysis of glucose-6-phosphate, an acetyl-CoA and malonyl-CoA precursor (Cardenas and 
Da Silva, 2014). Lian et al redirected glycolytic flux to the production of acetyl-CoA via 
gene inactivation of ADH1 and ADH4 from the competing ethanol pathway and GPD1 and 
GPD2 from the competing glycerol pathway (Lian et al., 2014). Chen et al over-expressed 
the endogenous ADH2 and ALD6 genes as well as a mutant heterologous acetyl-CoA 
synthetase from Salmonella enterica to redirect carbon flux from acetaldehyde to cytosolic 
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acetyl-CoA. They also reduced carbon loss from the pool of acetyl-CoA by inhibiting CIT2, 
a peroxisomal citrate synthase, and MLS1, a cytosolic malate synthase. Using this platform 
to produce α-santalene led to a four-fold increase in titer compared to the reference strain 
(Chen et al., 2013).
5.2 Strain engineering for high titers via toxicity mitigation
One challenge of using yeast as a cell factory to produce high titers of fungal polyketides is 
that many bioactive secondary metabolites are toxic in high concentrations (Martín et al., 
2005). Some strategies for producing toxic compounds in cell factories include using 
inducible promoters to decouple cell growth from compound production (Nevoigt, 2008); 
overlaying an organic solvent like dodecane on the top of the culture to remove the toxic 
compound as it is produced (Rodriguez et al., 2014); and overexpressing native, broadly-
specific transport proteins to remove toxic compounds from the cell (Valle Matta et al., 
2001). Native producers often evolve their own solutions to protect themselves from the 
presence of toxic compounds, such as specific transporter proteins or other enzymes that 
confer self-resistance to the native host (Martín et al., 2005). These self-resistance 
mechanisms can take the form of product-specific transporters like the putative transporter 
cazK from Chaetomium globosum and the putative efflux pump lovI from A. terreus 
(Kennedy et al., 1999; Winter et al., 2012b). Recently, Ley et al showed that integration of 
the putative efflux pump mlcE, from the compactin PKS cluster of P. citrinum, into the S. 
cerevisiae genome conferred increased resistance to mevastatin, lovastatin, and simvastatin, 
as compared to the wild type strain. MlcE was shown to be a specific transporter and 
restored the growth rates of yeast in the presence of up to ~800 mg/L of exogenously added 
lovastatin (Ley et al., 2015). Past analyses of fungal PKS clusters have primarily focused on 
reconstitution of the enzymes necessary for the biosynthesis of the encoded natural product, 
but, as Ley, et al showed, future work incorporating more of the putative self-resistance 
genes into heterologous polyketide production hosts has the potential to significantly 
increase final product titers (Ley et al., 2015).
6. Combinatorial biosynthesis of fungal PKSs in S. cerevisiae
Due to the contributions of natural products to the development of pharmaceuticals, there 
has been significant research toward discovering new natural products and engineering the 
biosynthesis of novel, unnatural bioactive compounds (Butler et al., 2013; Harvey, 2008; 
Newman and Cragg, 2012). One future goal is to set up an algorithm which takes a molecule 
of interest as input and outputs a sequence of natural PKS modules to produce the desired 
molecule (Poust et al., 2014). Although the synthesis of new “unnatural” natural products 
via combinatorial biosynthesis has been pursued in bacterial polyketide antibiotics for more 
than 15 years (McDaniel et al., 1999), there had been little progress in the field of fungal 
PKSs until recently. In 2013, Xu et al. reported the reprogramming of the first-ring 
cyclization of two benzenediol lactones (BDLs) (Xu et al., 2013c). BDLs are a family of 
fungal polyketides with diverse structural features and wide-ranging bioactivities. The BDL 
family is composed of resorcylic acid lactones (RALs), connected at C2–C7, and 
dihydroxyphenylacetic acid lactones (DALs), which feature a C3–C8 bond (Shen et al., 
2014). The biosynthesis of these fungal polyketides involves pairs of collaborating iPKSs: 
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an HR-PKS which passes its product to an NR-PKS for further modifications (Zhou et al., 
2008). Xu et al reconstituted heterologous HR-PKS and NR-PKS pairs from A. terreus and 
Chaetomium chiversii in BJ5464-NpgA and confirmed that the product template (PT) 
domains of the fungal NR-PKSs regiospecifically catalyzed the first-ring aldol cyclization, 
leading to the characteristically different polyketide folding modes of RALs and DALs. 
Next, rational reprogramming of the regiospecific first-ring cyclization was realized by 
domain replacement and site-directed mutagenesis (Xu et al., 2013c). Using the same 
BJ5464-NpgA system, Xu et al. expressed chimeric iPKSs enzyme pairs, resulting in the 
biosynthesis of unnatural BDLs, and found that the thioesterase (TE) domain acts as the 
decision gate for releasing the final product from a fungal NR-PKS. This indicated that in 
combinatorial biosynthesis, the TE domain must be able to accept altered polyketide 
intermediates and release unnatural natural products with the desired structure (Xu et al., 
2013b).
After the characterization of different domains of HR-PKSs and NR-PKSs in the 
biosynthetic pathways of BDLs, Xu et al. deployed yeast as a tool to investigate whether 
noncognate HR-PKS and NR-PKS pairs could interact with each other efficiently (Xu et al., 
2014). Through the combinatorial expression of random pairs of iPKSs subunits from four 
BDL biosynthetic pathways from A. terreus, C. chiversii, Lasiodiplodia theobromae, and 
Acremonium zeae in BJ5464-NpgA, a diverse library of BDL congeners was created. One of 
these unnatural polyketides had heat shock response-inducing activity that had previously 
been shown to block multiple cancer-causing pathways (Xu et al., 2014). This combinatorial 
work by Xu et al. provided more insight into PKS design rules, which will assist in future 
engineering of diverse natural products.
Another method for the biosynthesis of unnatural natural products is to feed artificial 
precursors to organisms heterologously expressing PKSs. Zhou et al and Gao et al both fed 
large acyl SNAC (N-acetylcysteamine thioester) substrates to fungal iPKSs expressed or 
purified from BJ5464-NpgA (Zhou et al., 2010; Gao et al., 2013). Both groups were able to 
produce unnatural analogs of the relevant natural product. Gao et al found that the efficiency 
of incorporation of the unnatural precursor analogs depended on the nature of the structural 
changes between these analogs and the natural precursors (Gao et al., 2013).
Finally, novel scaffolds can be found by combining existing heterologous natural product 
pathways in yeast and analyzing the resulting compounds. Klein et al took genes from 
known natural product pathways for alkaloids, benzoxazinoids, flavonoids, flavonols, 
lignans, polyunsaturated fatty acids, tetra- and diterpenoids, and type III polyketides and 14 
libraries of cDNA from 17 different organisms including plants, animals, fungi, and 
amaurochaetes and expressed them in different combinations on yeast artificial 
chromosomes in S. cerevisiae. The resulting compounds were screened for useful 
pharmaceutical activities and for the novelty of their scaffolds (Klein et al., 2014).
The successful combinatorial biosynthesis of fungal PKSs in S. cerevisiae has not only 
shown the utility of yeast for engineering improved production of natural products, but also 
extended this paradigm from bacterial polyketides to fungal polyketides (Agarwal and 
Moore, 2014).
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7. Discovering new natural products through genome mining and 
expression in S. cerevisiae
Another method of discovering new natural product scaffolds is to find novel natural 
product gene clusters. Top-down approaches, in which newly-discovered fungi are 
cultivated and their products analyzed, can lead to the discovery of new polyketides but are 
limited to compounds that are naturally synthesized in relative abundance in the native 
environment or under laboratory conditions. However, recent advances in genome 
sequencing and increased availability of fungal genomes can facilitate the discovery and 
analysis of new polyketides from putative clusters in previously studied organisms.
For over two decades, it has been known that fungal secondary metabolites are often 
synthesized by genes physically clustered in the genome (Smith et al., 1990a). As more 
sequenced fungal genomes become available, extensive genome mining efforts have been 
launched, leading to improved algorithms to annotate putative polyketide clusters in various 
fungi (Khaldi et al., 2010; Medema et al., 2011; Priebe et al., 2011). However, the 
metabolites encoded by clusters located this way are often unknown, and subsequently 
termed cryptic or orphan. Some silent clusters found via genome mining have not lead to 
any product in the native host under laboratory conditions (Brakhage, 2013; Yin et al., 
2013).
The products of fungal iPKSs cannot be predicted solely from their sequences, so the cluster 
must be induced in the native host, or expressed and analyzed in a heterologous host 
(Anyaogu and Mortensen, 2015; Bergmann et al., 2007). Despite the many advantages S. 
cerevisiae has as a heterologous host, introns in the fungal gene cluster coding regions must 
be completely removed before the heterologous pathway is expressed in yeast due to the 
significant differences between the introns of yeast and filamentous fungi (Anyaogu and 
Mortensen, 2015; Kupfer et al., 2004). However, the accuracy of fungal intron prediction 
has been improved by programs like FGENESH and homology alignment of known related 
genes to a putative cluster (Cacho et al., 2014; Zhang, 2002). Using intron prediction 
programs or direct cloning from RNA, if possible, should allow entire clusters discovered 
through genome mining to be cloned and expressed in yeast. As discussed previously, 
Ishiuchi et al used their ExRec method of cloning from a pool of total RNA isolated from 
various fungi to express several heterologous PKSs in yeast (Ishiuchi et al., 2012). Despite 
this progress, and its success as a platform for the exploration of silent bacterial PKS 
clusters, S. cerevisiae has been underutilized for exploring new silent fungal PKS clusters 
(Feng et al., 2010; Kang and Brady, 2014; Montiel et al., 2015). The technology and tools 
are available to discover new fungal natural products with yeast if, as these authors hope, 
more groups begin to utilize them.
8. Conclusions
A number of useful synthetic biology strategies have been developed in S. cerevisiae that 
make it a versatile tool for the discovery, characterization, and production of PKSs and their 
products. Yeast has been used as a host for cloning or purifying protein and as a tool for 
ascertaining the function of enzymes in a PKS cluster as well as for individual modules of 
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PKSs. In addition, this organism has been engineered as a host for testing biosynthesis of 
unnatural “natural” products, for screening bioactive compounds to find treatments for 
specific conditions, and for use as an industrial production host for heterologous pathways.
With such a versatile tool as yeast available, it is remarkable that more work has not been 
done with fungal PKSs in yeast. The literature is abundant with examples of yeast as a 
heterologous host for plant and bacterial PKSs, but yeast has been surprisingly underutilized 
for fungal PKSs. There is a rich variety of fungal natural products left to be discovered, 
characterized, and engineered. The future of this field will involve a greater utilization of 
heterologous fungal PKS expression in yeast, especially of cryptic clusters, in order to aid in 
the discovery and production of chemically diverse compounds that will have impacts in 
fields such as fuels and drug discovery.
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1. The well-developed genetic toolbox of Saccharomyces cerevisiae has been used 
to circumvent the challenge of genetic manipulation of polyketide pathways in 
native filamentous fungi hosts.
2. Yeast homologous recombination has been a powerful tool for exploration of 
fungal polyketides and their biosynthetic pathways.
3. Metabolic engineering in yeast has led to high titers of functional polyketide 
synthases and increased polyketide titers.
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Examples of important fungal polyketides
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The domains of several types of iterative type I polyketide synthases (iPKSs) are shown 
here. The PKS domains abbreviated here are as follows: KS (Keto-synthase), AT 
(Acyltransferase), DH (Dehydratase), CmeT (C-methyltransferase), ER (Enoylreductase), 
KR (Ketoreductase), ACP (Acyl carrier protein), TE (Thioesterase), PT (Product template), 
MAT (malonyl-CoA:ACP acyltransferase), and CON (Condensation).
The PKS-NRPS hybrid also contains Non Ribosomal Peptide Synthetase domains as 
follows: C (Condensation), A (Adenylation), T (Thiolation), and R (Reduction).
The example below shows the action of a nonaketide synthase, LovB, and its partner 
enoylreductase, LovC, from the lovastatin pathway of Aspergillus terreus.
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Cloning of large DNA fragments based on the recombination of yeast
A Capture of large DNA fragments from genomic DNA
B Assembly of interested gene cluster from overlapping cosmids
C Assembly of interested pathway from overlapping PCR products
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This figure outlines the route from the discovery of novel polyketides to high production in 
yeast, using the tools and methods discussed in this review.
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